The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

Behavioral and Psychiatric Symptoms of Dementia Clinical Trial

Official title: Antipsychotic Use Within the Program of All-inclusive Care for the Elderly (PACE)

Status Completed

Clinical Trial Summary

The aim of this study is to retrospectively evaluate and describe the use of antipsychotics among participants enrolled in the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.

Clinical Trial Description

Much national attention has been given to assessing and reducing the use of antipsychotics among nursing home residents, yet comparatively little attention has focused on antipsychotic use among older adults receiving care in community-based settings. The primary objective of this study is to determine the prevalence of antipsychotic use among a nationally representative sample of nursing home-eligible older adults in a community-based practice setting known as Program of All-inclusive Care for the Elderly (PACE). The secondary objectives are focused on characterizing antipsychotic use within PACE and for these participants. Specifically, the investigator's secondary objectives are to describe patterns of other drugs concomitantly used with antipsychotics (e.g., benzodiazepines, opioids) and to identify clinically relevant drug-drug interactions involving antipsychotics. ;

Related Conditions & MeSH terms

• Behavioral and Psychiatric Symptoms of Dementia
• Dementia

• NCT number: NCT03692182
• Study type: Observational
• Source: Tabula Rasa HealthCare
• Status: Completed
• Start date: January 2017
• Completion date: March 2019